Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Canopy Biosciences logo — Providing access to cutting-edge spatial biology and multi-o...

Canopy Biosciences

Providing access to cutting-edge spatial biology and multi-omic tools.

Founded 2016 United States United States 26 employees Venture round Total: $4.40M Biopharma, Biotechnology +2

General Information

Company Name Canopy Biosciences
Founded Year 2016
Location United States United States
Employees 26
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Canopy Biosciences. To contact Canopy Biosciences, visit canopybiosciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Canopy Biosciences compare?

A PDF of Canopy Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Canopy Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Canopy Biosciences

Canopy Biosciences is a biotech startup that aims to revolutionize the field of spatial biology and multi-omic tools. Acquired by Bruker, the company is driven by its mission to empower innovation by providing biomedical researchers with cutting-edge technologies to accelerate scientific discovery. Its proprietary technology, ChipCytometry™, offers a quantitative multiplex immunofluorescence imaging method for the spatial analysis of complex tissues and mapping of cell populations with single-cell resolution. Supported by Canopy Spatial Services™ with a CLIA-certified laboratory, the company offers a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction. Established in 2016 and headquartered in the United States, Canopy Biosciences secured a Venture Round investment on 30 April 2019 from Ampersand Capital Partners. With its focus on propelling scientific discovery and its backing from notable investors, Canopy Biosciences is poised to make significant contributions to the biotech and healthcare industries. Learn more at CanopyBiosciences.com.

Business keywords: Spatial Biology, Multi-omic Tools, Gene Editing, Personalized Medicine, Transcriptomics, CLIA, CRO Services, Multiplex Imaging, Digital Pathology, Immunofluorescence, Tissue Analysis, Proteomics, Spatial Phenotyping

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Ampersand Capital Partners
Ampersand Capital Partners
30 Apr 2019
Series A $2.40M 6
BioGenerator Missouri Technology Corporation (MTC) Archangel Investors Limited
BioGenerator, Missouri Technology Corporation (MTC) +4
22 May 2018
Seed Round $2.00M 1
Ampersand Capital Partners
Ampersand Capital Partners
30 Jan 2017

Canopy Biosciences Alternatives & Competitors

View All Alternatives
Canopy Biosciences vs
Akoya Biosciences, Inc.
Akoya Biosciences, Inc. United States

Bringing biology into focus—Akoya Biosciences is now Quanterix® Spatial, The Spatial Biology Company...

Acquired
99 employees
Biotechnology, Health Care
Compare Canopy Biosciences vs Akoya Biosciences, Inc.
Canopy Biosciences vs
Lunaphore (a Bio-Techne brand)
Lunaphore (a Bio-Techne brand) Switzerland

Lunaphore is now under the portfolio brand: Bio-Techne Spatial. Follow our new page for updates.

Series D
84 employees
Biotechnology, Health Care
Canopy Biosciences vs
NanoString Technologies, Inc.
NanoString Technologies, Inc. United States

Mapping the universe of biology 🧬

IPO
219 employees
Biotechnology, Health Care
Compare Canopy Biosciences vs NanoString Technologies, Inc.
View all alternatives

FAQ About Canopy Biosciences

Providing access to cutting-edge spatial biology and multi-omic tools.
Canopy Biosciences was founded in 2016.
Canopy Biosciences is headquartered in United States.
Canopy Biosciences operates in Biopharma, Biotechnology, Health Care and Life Sciences. Its work centres on Spatial Biology, Multi-omic Tools, Gene Editing and Personalized Medicine.
Canopy Biosciences has approximately 26 employees.
Canopy Biosciences has completed 3 funding rounds, raising a total of $4.40M. The latest funding stage is Venture round.
Top alternatives and competitors to Canopy Biosciences include Akoya Biosciences, Inc., Lunaphore (a Bio-Techne brand), NanoString Technologies, Inc., Singular Genomics, Definiens, The Tissue Phenomics Company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Canopy Biosciences and Akoya Biosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Canopy Biosciences, https://bouncewatch.com/company/canopy-biosciences, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout